<DOC>
	<DOCNO>NCT00443209</DOCNO>
	<brief_summary>The purpose study investigate safety tolerability telcagepant ( MK-0974 ) long-term treatment acute migraine adult participant . The primary hypothesis study telcagepant well tolerate long-term treatment acute migraine adult participant .</brief_summary>
	<brief_title>Telcagepant ( MK-0974 ) Long-Term Safety Study Adult Participants With Acute Migraine ( MK-0974-012 )</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>At least 1 year history migraine ( without aura ) Females child bear potential must use acceptable contraception throughout trial In general good health base screen assessment Pregnant/breastfeeding ( female expect conceive study period ) History evidence stroke/transient ischemic attack , heart disease , coronary artery vasospasm , significant underlie cardiovascular disease , uncontrolled hypertension ( high blood pressure ) , uncontrolled diabetes , human immunodeficiency virus ( HIV ) disease Major depression , pain syndrome might interfere study assessment , psychiatric condition , dementia , significant neurological disorder ( migraine ) History gastric , small intestinal surgery , disease cause malabsorption History cancer within last 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>